Low-dose mitotane-induced neurological and endocrinological complication in a 5-year-old girl with adrenocortical carcinoma
Mitotane is an adrenolytic drug that exhibits therapeutic effects within a narrow target range (14-20 μg/dL). Various complications develop if the upper limit is exceeded. We present the case of a 5-year-old girl with breast development, acne, and pubic hair who was diagnosed with an adrenal mass th...
Saved in:
Main Authors: | You Joung Heo (Author), Jae Ho Yoo (Author), Yun Soo Choe (Author), Sang Hee Park (Author), Seung Bok Lee (Author), Hyun A Kim (Author), Jung Yoon Choi (Author), Young Ah Lee (Author), Byung Chan Lim (Author), Hee Won Chueh (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pediatric Endocrinology,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of o,p'-DDE, a Mitotane Metabolite, in an Adrenocortical Carcinoma Cell Line
by: Camila Bach, et al.
Published: (2022) -
Isosexual precocious pseudopuberty during mitotane treatment in a child with adrenocortical carcinoma: A case report
by: Maria Riedmeier, et al.
Published: (2024) -
Ambient air pollution and endocrinologic disorders in childhood
by: You Joung Heo, et al.
Published: (2021) -
Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?
by: Yoann Cazaubon, et al.
Published: (2019) -
Mitotane Nanocarriers for the Treatment of Adrenocortical Carcinoma: Evaluation of Albumin-Stabilized Nanoparticles and Liposomes in a Preclinical In Vitro Study with 3D Spheroids
by: Carolin Langer, et al.
Published: (2022)